ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15

Claire L. Sutherland(IDEX Corporation (United States)), David Cosman(IDEX Corporation (United States)), Brian Rabinovich(Ontario Institute for Cancer Research), Robert E. Miller(Amgen (United States)), Pierre Brawand(Amgen (United States)), N. Jan Chalupny(IDEX Corporation (United States))
Blood
April 19, 2006
Cited by 106


Related Papers